NBY NovaBay Pharmaceuticals Inc

USD 0.68 0.00 ( 0.00)%
Icon

NovaBay Pharmaceuticals Inc (NBY) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NYE
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.68

0.00 (0.00)%

USD 3.39M

0.03M

USD 0.85(+24.82%)

USD 1.00 (+46.84%)

Icon

NBY

NovaBay Pharmaceuticals Inc (USD)
COMMON STOCK | NYE
USD 0.68
0.00 ( 0.00)%

NovaBay Pharmaceuticals Inc (NBY) Stock Forecast

USD 0.85
(+24.82%)

Based on the NovaBay Pharmaceuticals Inc stock forecast from 1 analysts, the average analyst target price for NovaBay Pharmaceuticals Inc is USD 0.85 over the next 12 months. NovaBay Pharmaceuticals Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of NovaBay Pharmaceuticals Inc is Bearish, which is based on 2 positive signals and 5 negative signals. At the last closing, NovaBay Pharmaceuticals Inc’s stock price was USD 0.68. NovaBay Pharmaceuticals Inc’s stock price has changed by -4.46% over the past week, +14.59% over the past month and -93.68% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...